Session Details
Oral Oresentation 12
Fri. Jul 11, 2025 3:30 PM - 4:45 PM JST
Fri. Jul 11, 2025 6:30 AM - 7:45 AM UTC
Fri. Jul 11, 2025 6:30 AM - 7:45 AM UTC
Room Ⅴ(Makuhari Messe Meeting Room 104)
Chair:Kaoru Yokoyama, Shuhei Hosomi
[O12-01]A Multicenter Cross-Sectional Survey of Patient-Reported Mesalazine-Related Adverse Events in Ulcerative Colitis: Real-World Evidence from 47 Centers in China
*Yuge Wei1, Jun Shen2, Jie Liang3, Ren Mao4, Li Wang5, Hong Yang6 (1. 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2. Division of Gastroenterology and Hepatology, Baoshan Branch, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China, 3. National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China, 4. Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Road 2nd, Guangzhou 510080, China, 5. Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China, 6. Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China)
[O12-02]The Effects of Discontinuing 5-ASA on Clinical Outcomes in Ulcerative Colitis Patients After Inducing Remission by Advanced Therapy: A Multicenter Retrospective Cohort Study
*Yasuki Sano1, Naoto Yagi1, Yuka Ito1, Eiko Saito1, Yusuke Honzawa1, Norimasa Fukata1, Makoto Naganuma1 (1. Department of Gastroenterology, Kansai Medical University, Japan)
[O12-03]Prevalence and Clinical Outcomes in Ulcerative Colitis Patients with Aminosalicylate Intolerance: A Multicenter Retrospective I-BRITE Study
*Shintaro Akiyama1, Yuaka Ito2, Mamiko Shiroyama1, Masanori Ochi3, Hiroshi Kashimura4, Junichi Iwamoto5, Rie Saito6, Tsuyoshi Kaneko6, Kazuto Ikezawa7, Yoshinori Hiroshima8, Takashi Mamiya9, Satoshi Fukuda10, Kazuho Ikeda10, Masaaki Nishi11, Hiroyuki Ariga12, Junya Kashimura12, Masaomi Nagase13, Kiichiro Tsuchiya1 (1. Department of Gastroenterology, Institute of Medicine, University of Tsukuba, 2. Department of Gastroenterology NHO Mito Medical Center, 3. Department of Gastroenterology, Hitachi General Hospital, 4. Department of Gastroenterology, Mito Saiseikai General Hospital, 5. Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center,, 6. Division of Gastroenterology, Tsukuba Central Hospital, 7. Division of Gastroenterology, Tsukuba Memorial Hospital, 8. Division of Gastroenterology, Hitachinaka General Hospital, 9. Department of Gastroenterology, Ryugasaki Saiseikai Hospital, 10. Department of Gastroenterology, Koyama Memorial Hospital, 11. Department of Gastroenterology, Tsukuba Medical Center Hospital, 12. Department of Gastroenterology, Mito Kyodo General Hospital, 13. Department of Gastroenterology, Kasumigaura Medical Center)
[O12-04]A National Multicenter Survey on the Current Status of 5-ASA Treatment and Awareness among Elderly Patients with Mild to Moderate Ulcerative Colitis in China
*Jun Shen1, Hong Yang2, Jie Liang3, Ren Mao4, Li Wang5 (1. Department of Gastroenterology, Renji Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China, 2. Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, 3. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Xi'an, China, 4. Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China, 5. Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China)
[O12-05]Adherence to Mesalazine in Maintenance Therapy for Ulcerative Colitis: A National Multicenter Survey
*Jun Shen1, Hong Yang2, Jie Liang3, Ren Mao4, Li Wang5 (1. Department of Gastroenterology, Renji Hospital, Shanghai Jiaotong University, School of Medicine, 2. Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China , 3. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Xi'an, China. , 4. Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China, 5. Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, China)
[O12-06]Impact of Concomitant 5-Aminosalicylic Acid on Ustekinumab and Vedolizumab Therapy for Inflammatory Bowel Disease: A Retrospective Medical Claims Analysis
*Shuhei HOSOMI1, Yu Nishida1, Koji Fujimoto1, Yumie Kobayashi1, Rieko Nakata1, Fumio Tanaka1, Yasuhiro Fujiwara1 (1. Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University)
[O12-07]Outcome of 5-aminosalicylate continuation versus discontinuation in patients with inflammatory bowel disease started on biologic therapy – A systematic review and Meta-analysis
Suprabhat Giri1, Girish Kumar Pati2, Anuraag Jena2, Subhash Chandra Samal2, *Vivek Ahuja2, Manjit Kanungo2, Jimmy Narayan2, S Rakesh Kumar2, Swarup Kumar Patnaik2, Sarvjeet Kumar2, Vasista Palnati2 (1. Kalinga Institute of Medical Sciences, Bhubaneswar , Odisha, 2. Institute of Medical Sciences & SUM Hospital, Bhubaneswar, Odisha)
[O12-08]Endoscopic severity at presentation and C-reactive protein predict immediate and twelve-month outcomes of second-line medical therapy in acute severe ulcerative colitis
*Deloshaan Subhaharan1,5, Pradeep Kakkadasam Ramaswamy1, John Edwards1, Lauren White2, Desmond Patrick2, Asif Shahzad3, Laura Willmann1, Hadi Moattar1, Dheeraj Shukla1, Naveed Ishaq1, Maneesha Bhullar1, Alexander Dorrington1, Jack Satsangi4, Waled Mohsen1 (1. Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia, 2. Department of Gastroenterology, Sunshine Coast University Hospital, Sunshine Coast, Australia, 3. Department of Gastroenterology, Logan Hospital, Logan, Australia, 4. Department of Gastroenterology, John Radcliffe Hospital, Oxford, United Kingdom, 5. Bond University, Gold Coast, Australia)
[O12-09]Practices, Patterns, and Challenges in the Management of Acute Severe Ulcerative Colitis in a Low Middle-Income Country: A Survey-Based Study
Arshdeep Singh1, *Arshia Bhardwaj1, Riya Sharma1, Ramit Mahajan1, Vandana Midha1, Ajit Sood1 (1. Dayanand Medical College and Hospital, Ludhiana, India)
[O12-10]The Clinical Spectrum of Acute Severe Ulcerative Colitis in the Biologic Era
*Arshdeep Singh1, Arshia Bhardwaj1, Riya Sharma1, Vandana Midha1, Ramit Mahajan1, Ajit Sood1 (1. Dayanand Medical College and Hospital, Ludhiana, India)
[O12-11]Comparative Clinical Outcomes of Advanced Therapy in Bio-naive versus Bio-experienced Patients Hospitalized with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study
Soyoung Kim1, Min Kyu Kim1, Cheol-Hyung Lee1, Jong Whan Kim1, Songhyun Lee1, Seung Wook Hong1, Sang Hyoung Park1,2, Dong-Hoon Yang1, Byong Duk Ye1,2, Jeong-Sik Byeon1, Seung-Jae Myung1, Suk-Kyun Yang1,2, *Sung Wook Hwang1,2 (1. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 2. Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine)
[O12-12]PREVALENCE OF CLOSTRIDIOIDES DIFFICILE IN MODERATE TO SEVERE ULCERATIVE COLITIS
*Hiteshbhai Panchal1, Dr Amarender Puri1, Dr Sukrit Sud1 (1. Medanta the medicity)